Partnerships, business and growth at CPhI 2018 Madrid

Hosted in the landscape of one of Europe’s burgeoning biotech and pharma hubs, CPhI Worldwide promises to be an unmissable opportunity to discover the latest and most innovative advancements, catch up with old contacts and form vital new partnerships that will push the industry to the next level

picture of

Breaking News

Eli Lilly's modernisation plan cuts 250 jobs in France

The Fegersheim site will see a €100 million investment in new technology

Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment

Eli Lilly’s acquisition of Loxo Oncology marks the second multibillion-dollar deal in 2019 following the recent BMS and ...

Exscientia initiates sixth AI drug discovery partnership

Exscientia to receive up to CHF67 million in upfront payments, research support and milestone payments in discovery ...

Only a handful of pharma companies are developing the urgently needed new medicines for the poor

The development of new medical products that are considered the highest priority for people in developing countries is ...

Cytoreason and Pfizer to use machine learning model of the immune system for drug discovery

CytoReason, a leader in machine learning for drug discovery and development, has entered into a collaboration agreement ...

PCI Pharma Services announces a more than $20 million expansion of biotech technologies including advanced injectable delivery forms

Demand for biotech packaging drives significant PCI investment at multiple locations worldwide

A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and ...

Almac Group flows into continuous technology

Almac Sciences has expanded its technology capabilities within its API services and chemical development portfolio with ...

Catalent invests $200 million to expand biologics capacity and capabilities

Catalent has commenced a $200 million capital investment in its biologics business to expand drug substance ...

CFO 4.0: How the new breed of pharma industry CFOs is enabling digital transformation

Deciding to embark on digital transformation is one thing for a manufacturer. Analysing and clearly articulating the ...

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Middle East and Africa pharma economy to reach US$38.8 bn by 2021

CPhI Middle East and Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government ...

BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants

Following the Bristol-Myers Squibb (BMS) announcement on 3 January 2019 that it will acquire Celgene in a cash and ...

Drug pricing and reimbursement concerns will remain the leading impediment to industry growth in 2019

In 2019, drug pricing pressure from regulators, patients, politicians and payers will remain and aggressive negotiation ...